http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101509168-B1

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2121-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-546
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-61
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5395
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-545
filingDate 2013-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2015-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2015-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-101509168-B1
titleOfInvention Sustained-release preparations of cephalosporin antibiotic and Sustained-release pharmaceutical composition comprising the same
abstract The present invention relates to a sustained-release preparation of cephalosporin antibiotics, a sustained-release pharmaceutical composition comprising the same, and a method for producing the sustained-release formulation. The suspension injections containing the sustained-release preparation of cephalosporin antibiotic of the present invention can solve the inconvenience of the conventional formulation for three consecutive days because the efficacy is continuously exhibited even with a single administration, and it is left for a long time The stability is high. Therefore, the present invention can be usefully used as a therapeutic agent for antibiotics and respiratory diseases of animals.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107951842-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107951842-A
priorityDate 2013-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20080026109-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453213080
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5361919
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397365
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60651
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6857980
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284359
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6321413
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452328128
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419493047
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413782405
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419501020
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID72543801
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491667
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6399253
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71816151
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5282242
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419502768
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419500687
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426098768
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407070054
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5484735

Total number of triples: 42.